https://wilsonresearchlab.org/publication/parkinsons-disease-is-characterized-by-vitamin-b6-dependent-inflammatory-kynurenine-pathway-dysfunction-2/2026-05-23T18:48:36-04:00https://wilsonresearchlab.org/publication/a-cerebrospinal-fluid-synaptic-protein-biomarker-for-prediction-of-resilience-versus-decline-in-alzheimers-disease/2026-02-25T20:41:22-05:00https://wilsonresearchlab.org/publication/top-down-attention-and-alzheimers-pathology-affect-cortical-selectivity-during-learning-influencing-episodic-memory-in-older-adults/2026-02-21T17:56:28-05:00https://wilsonresearchlab.org/publication/multi-cohort-cerebrospinal-fluid-proteomics-identifies-robust-molecular-signatures-for-asymptomatic-and-symptomatic-alzheimers-disease/2026-02-21T17:49:56-05:00https://wilsonresearchlab.org/publication/a-single-cell-atlas-to-map-sex-specific-gene-expression-changes-in-blood-upon-neurodegeneration/2026-02-21T17:48:40-05:00https://wilsonresearchlab.org/publication/18f-pi-2620-tau-pet-is-associated-with-cognitive-and-motor-impairment-in-lewy-body-disease/2026-02-21T17:58:46-05:00https://wilsonresearchlab.org/publication/plasma-a%ce%b242-a%ce%b240-is-sensitive-to-cerebral-a%ce%b2-accumulation-across-the-alzheimers-disease-spectrum/2026-02-25T20:37:58-05:00https://wilsonresearchlab.org/publication/trem1-disrupts-myeloid-bioenergetics-and-cognitive-function-in-aging-and-alzheimers-disease-mouse-models/2026-05-23T18:47:24-04:00https://wilsonresearchlab.org/publication/1736/2026-02-21T18:02:01-05:00https://wilsonresearchlab.org/publication/proteogenomic-analysis-of-human-cerebrospinal-fluid-identifies-neurologically-relevant-regulation-and-implicated-causal-proteins-for-alzheimers-disease/2026-02-21T18:04:53-05:00https://wilsonresearchlab.org/publication/plasma-ptau181-reveals-a-pathological-signature-that-predicts-cognitive-outcomes-in-lewy-body-disease/2026-02-21T18:03:54-05:00https://wilsonresearchlab.org/publication/multiple-biomarkers-improve-diagnostic-accuracy-across-lewy-body-and-alzheimers-disease-spectra/2026-02-21T18:01:03-05:00https://wilsonresearchlab.org/publication/nanolithium-a-new-treatment-approach-to-alzheimers-disease-a-review-of-existing-evidence-and-clinical-perspectives/2026-02-21T17:53:01-05:00https://wilsonresearchlab.org/publication/post-translational-modifications-linked-to-preclinical-alzheimers-disease-related-pathological-and-cognitive-changes/2026-02-21T18:03:06-05:00https://wilsonresearchlab.org/publication/organ-specific-aging-signatures-in-the-plasma-proteome-track-health-and-disease/2026-02-25T20:40:15-05:00https://wilsonresearchlab.org/publication/pet-imaging-of-trem1-identifies-cns-infiltrating-myeloid-cells-in-a-mouse-model-of-multiple-sclerosis/2026-02-21T18:08:39-05:00https://wilsonresearchlab.org/publication/performance-of-a-fully-automated-lumipulse-plasma-phospho-tau181-assay-for-alzheimers-disease/2026-02-21T18:07:15-05:00https://wilsonresearchlab.org/publication/%ce%b1-synuclein-seed-amplification-in-csf-and-brain-from-patients-with-different-brain-distributions-of-pathological-%ce%b1-synuclein-in-the-context-of-co-pathology-and-non-lbd-diagnoses/2026-02-21T18:06:41-05:00https://wilsonresearchlab.org/publication/limited-proteolysis-mass-spectrometry-reveals-aging-associated-changes-in-cerebrospinal-fluid-protein-abundances-and-structures/2026-02-21T18:07:54-05:00https://wilsonresearchlab.org/publication/csf-proteomic-profiling-with-amyloid-and-tau-pathology-identifies-distinctive-sex-specific-alteration-of-multiple-proteins-involved-in-alzheimers-disease/2026-04-21T11:48:44-04:00https://wilsonresearchlab.org/publication/plasma-biomarkers-of-tau-and-neurodegeneration-during-major-cardiac-and-noncardiac-surgery/2026-02-25T20:41:02-05:00https://wilsonresearchlab.org/publication/tam-ping-down-amyloid-in-alzheimers-disease/2026-02-22T14:27:22-05:00https://wilsonresearchlab.org/publication/association-of-csf-biomarkers-with-hippocampal-dependent-memory-in-preclinical-alzheimer-disease/2026-02-22T14:29:39-05:00https://wilsonresearchlab.org/publication/soluble-trem2-is-elevated-in-parkinsons-disease-subgroups-with-increased-csf-tau/2026-02-22T14:34:30-05:00https://wilsonresearchlab.org/publication/mucin-binding-protein-shuttles-enable-delivery-of-brain-targeted-therapeutics/2026-04-14T09:56:55-04:00https://wilsonresearchlab.org/publication/large-scale-csf-and-plasma-proteomics-reveal-immune-dysregulation-synaptic-impairment-and-extracellular-matrix-alterations-in-neurodegeneration/2026-04-21T11:54:35-04:00https://wilsonresearchlab.org/publication/pre-analytical-guidelines-for-blood-and-csf-biomarkers-2025-recommendations-from-the-nacc-adrc-biofluid-biomarker-best-practices-workgroup/2026-05-23T17:58:03-04:00https://wilsonresearchlab.org/publication/multivariate-patterns-of-plasma-biomarkers-predict-region-specific-alzheimers-pathology-and-cognitive-decline-across-independent-cohorts/2026-05-23T18:07:33-04:00https://wilsonresearchlab.org/publication/plasma-phosphorylated-tau-217-detects-amyloid-%ce%b2-in-neuronal-synuclein-disease/2026-05-23T18:07:17-04:00https://wilsonresearchlab.org/publication/effects-of-%ce%b1-synuclein-pathology-on-synaptic-dysfunction-and-clinical-outcomes-in-normal-aging/2026-05-23T18:44:38-04:00https://wilsonresearchlab.org/publication/relation-of-blood-based-inflammation-conditional-networks-to-key-immune-health-status-and-alzheimers-biomarkers-in-aging-adults/2026-05-23T18:09:34-04:00https://wilsonresearchlab.org/publication/plasma-proteomic-signatures-of-preclinical-alzheimers-disease-in-clinically-unimpaired-older-adults/2026-05-23T18:14:18-04:00